Pyridyl Piperidine Synthesis for Orexin Antagonists

The patent segments the development of orexin receptor antagonists into distinct chemical series (pyridyl piperidine compounds) with specific structural features. By dividing the therapeutic approach into targeted molecular structures that selectively bind to orexin receptors, the invention provides reliable antagonistic activity while maintaining versatility through multiple related compounds with potentially different pharmacological profiles

The patent employs parameter changes by modifying chemical structures of pyridyl piperidine compounds to optimize receptor binding affinity and selectivity. By systematically varying molecular parameters such as substituent groups on the pyridine ring and piperidine moiety, the invention achieves effective antagonism across different orexin receptor subtypes, thereby improving therapeutic reliability while expanding the available antagonist options

The patent applies preliminary action by pre-synthesizing key intermediates such as pyridyl piperidine cores and protecting groups before final assembly. By preparing these building blocks in advance with predetermined structural features, the synthesis process for active antagonist compounds becomes more systematic and manageable, reducing overall process complexity while maintaining reliable production of therapeutically effective molecules

The patent uses intermediary compounds as mediators in the synthesis pathway. Protected pyridyl piperidine intermediates serve as stable platforms that facilitate subsequent coupling reactions with various aromatic carboxylic acid derivatives. These intermediary structures simplify the overall synthesis by breaking down complex molecule construction into manageable stages, each with controlled chemistry and predictable outcomes